288 related articles for article (PubMed ID: 11714831)
1. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
[TBL] [Abstract][Full Text] [Related]
2. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR.
Hartt JK; Barish G; Murphy PM; Gao JL
J Exp Med; 1999 Sep; 190(5):741-7. PubMed ID: 10477558
[TBL] [Abstract][Full Text] [Related]
3. The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor.
Hartt JK; Liang T; Sahagun-Ruiz A; Wang JM; Gao JL; Murphy PM
Biochem Biophys Res Commun; 2000 Jun; 272(3):699-704. PubMed ID: 10860818
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of spinorphin, a novel endogenous regulator, on chemotaxis, O2- generation, and exocytosis by N-formylmethionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.
Yamamoto Y; Kanazawa T; Shimamura M; Ueki M; Hazato T
Biochem Pharmacol; 1997 Sep; 54(6):695-701. PubMed ID: 9310346
[TBL] [Abstract][Full Text] [Related]
5. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.
Lavigne MC; Murphy PM; Leto TL; Gao JL
Cell Immunol; 2002; 218(1-2):7-12. PubMed ID: 12470609
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils.
Liang TS; Wang JM; Murphy PM; Gao JL
Biochem Biophys Res Commun; 2000 Apr; 270(2):331-5. PubMed ID: 10753626
[TBL] [Abstract][Full Text] [Related]
7. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
[TBL] [Abstract][Full Text] [Related]
8. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
9. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
[TBL] [Abstract][Full Text] [Related]
10. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils.
Southgate EL; He RL; Gao JL; Murphy PM; Nanamori M; Ye RD
J Immunol; 2008 Jul; 181(2):1429-37. PubMed ID: 18606697
[TBL] [Abstract][Full Text] [Related]
11. Conformational aspects of human formylpeptide receptor antagonists.
Scatturin A; Vertuani G; Pecoraro R; Dalpiaz A; Boggian M; Ferretti ME; Spisani S
Arzneimittelforschung; 1999 Oct; 49(10):873-7. PubMed ID: 10554666
[TBL] [Abstract][Full Text] [Related]
12. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
[No Abstract] [Full Text] [Related]
13. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues.
Derian CK; Solomon HF; Higgins JD; Beblavy MJ; Santulli RJ; Bridger GJ; Pike MC; Kroon DJ; Fischman AJ
Biochemistry; 1996 Jan; 35(4):1265-9. PubMed ID: 8573582
[TBL] [Abstract][Full Text] [Related]
14. Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects.
Dalpiaz A; Ferretti ME; Pecoraro R; Fabbri E; Traniello S; Scatturin A; Spisani S
Biochim Biophys Acta; 1999 Jun; 1432(1):27-39. PubMed ID: 10366725
[TBL] [Abstract][Full Text] [Related]
15. The mechanism for activation of the neutrophil NADPH-oxidase by the peptides formyl-Met-Leu-Phe and Trp-Lys-Tyr-Met-Val-Met differs from that for interleukin-8.
Fu H; Bylund J; Karlsson A; Pellmé S; Dahlgren C
Immunology; 2004 Jun; 112(2):201-10. PubMed ID: 15147563
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis.
Hsu MH; Chiang SC; Ye RD; Prossnitz ER
J Biol Chem; 1997 Nov; 272(47):29426-9. PubMed ID: 9367998
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.
Sogawa Y; Ohyama T; Maeda H; Hirahara K
Immunology; 2011 Mar; 132(3):441-50. PubMed ID: 21039475
[TBL] [Abstract][Full Text] [Related]
18. High constitutive activity of the human formyl peptide receptor.
Wenzel-Seifert K; Hurt CM; Seifert R
J Biol Chem; 1998 Sep; 273(37):24181-9. PubMed ID: 9727041
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain.
Tiffany HL; Lavigne MC; Cui YH; Wang JM; Leto TL; Gao JL; Murphy PM
J Biol Chem; 2001 Jun; 276(26):23645-52. PubMed ID: 11316806
[TBL] [Abstract][Full Text] [Related]
20. C-terminal tail phosphorylation of N-formyl peptide receptor: differential recognition of two neutrophil chemoattractant receptors by monoclonal antibodies NFPR1 and NFPR2.
Riesselman M; Miettinen HM; Gripentrog JM; Lord CI; Mumey B; Dratz EA; Stie J; Taylor RM; Jesaitis AJ
J Immunol; 2007 Aug; 179(4):2520-31. PubMed ID: 17675514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
